# Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure

> **NCT05274984** · PHASE1 · UNKNOWN · sponsor: **Iuliu Hatieganu University of Medicine and Pharmacy** · enrollment: 100 (estimated)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** Placebo
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT05274984
- **Lead sponsor:** Iuliu Hatieganu University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-03
- **Primary completion:** 2022-03-03
- **Final completion:** 2022-04-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274984, "Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05274984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*